|
G |
Aif1 |
allograft inflammatory factor 1 |
multiple interactions decreases expression |
ISO |
Minocycline affects the reaction [GPX1 protein affects the expression of AIF1 protein]; Minocycline inhibits the reaction [Methamphetamine results in increased expression of AIF1 protein]; Minocycline inhibits the reaction [Morphine results in increased expression of AIF1 protein] Minocycline results in decreased expression of AIF1 protein |
CTD |
PMID:32916201 PMID:36682417 PMID:37394652 |
|
NCBI chr20:3,646,784...3,652,670
Ensembl chr20:3,646,777...3,652,668
|
|
G |
Aifm1 |
apoptosis inducing factor, mitochondria associated 1 |
multiple interactions decreases secretion |
EXP ISO |
Minocycline inhibits the reaction [HTT protein mutant form results in increased secretion of and results in increased localization of AIFM1 protein] Minocycline inhibits the reaction [Kainic Acid results in increased localization of AIFM1 protein] Minocycline results in decreased secretion of AIFM1 protein |
CTD |
PMID:12930891 PMID:16469440 |
|
NCBI chr X:127,650,223...127,689,356
Ensembl chr X:127,650,226...127,689,256
|
|
G |
App |
amyloid beta precursor protein |
multiple interactions |
ISO EXP |
Minocycline inhibits the reaction [APP gene mutant form results in increased phosphorylation of EIF2S1 protein] Minocycline inhibits the reaction [APP protein alternative form results in increased activity of CASP12 protein]; Minocycline inhibits the reaction [APP protein alternative form results in increased phosphorylation of EIF2AK2 protein]; Minocycline inhibits the reaction [APP protein alternative form results in increased phosphorylation of EIF2S1 protein] |
CTD |
PMID:17406652 |
|
NCBI chr11:24,019,774...24,236,584
Ensembl chr11:24,019,778...24,236,561
|
|
G |
Atf3 |
activating transcription factor 3 |
multiple interactions |
EXP |
Minocycline inhibits the reaction [Paclitaxel results in increased expression of ATF3 protein] |
CTD |
PMID:21050491 |
|
NCBI chr13:102,751,278...102,800,520
Ensembl chr13:102,751,321...102,764,631
|
|
G |
Atf6 |
activating transcription factor 6 |
multiple interactions |
EXP |
Minocycline inhibits the reaction [Paraquat results in increased expression of ATF6 protein] |
CTD |
PMID:22245251 |
|
NCBI chr13:82,927,579...83,106,381
Ensembl chr13:82,930,034...83,107,177
|
|
G |
Atp5f1a |
ATP synthase F1 subunit alpha |
multiple interactions |
ISO |
Minocycline inhibits the reaction [[Maneb co-treated with Paraquat] results in decreased expression of ATP5F1A protein] |
CTD |
PMID:23562983 |
|
NCBI chr18:71,292,406...71,300,342
Ensembl chr18:71,292,374...71,300,794
|
|
G |
Atp5pd |
ATP synthase peripheral stalk subunit d |
multiple interactions |
EXP |
Minocycline inhibits the reaction [cypermethrin results in decreased expression of ATP5PD protein] |
CTD |
PMID:21561882 |
|
NCBI chr10:100,657,700...100,662,960
Ensembl chr10:100,657,708...100,663,479
|
|
G |
Bace1 |
beta-secretase 1 |
multiple interactions |
ISO |
Minocycline inhibits the reaction [Copper results in increased expression of BACE1 mRNA] |
CTD |
PMID:18583042 |
|
NCBI chr 8:46,142,060...46,166,268
Ensembl chr 8:46,142,116...46,165,876
|
|
G |
Bak1 |
BCL2-antagonist/killer 1 |
multiple interactions |
EXP |
[Minocycline results in increased expression of BCL2 protein] which binds to BAK1 protein |
CTD |
PMID:15004018 |
|
NCBI chr20:5,100,480...5,109,669
Ensembl chr20:5,100,480...5,109,264
|
|
G |
Bax |
BCL2 associated X, apoptosis regulator |
multiple interactions decreases expression |
EXP ISO |
[Minocycline results in increased expression of BCL2 protein] which binds to BAX protein; Minocycline inhibits the reaction [Sodium Azide affects the localization of BAX protein] Minocycline results in decreased expression of BAX protein Minocycline inhibits the reaction [Rotenone results in increased expression of BAX protein] |
CTD |
PMID:15004018 PMID:15172883 PMID:33402167 |
|
NCBI chr 1:95,940,001...95,945,407
Ensembl chr 1:95,938,808...95,945,368
|
|
G |
Bcl2 |
BCL2, apoptosis regulator |
multiple interactions increases expression |
ISO EXP |
[Minocycline co-treated with Hydrogen Peroxide co-treated with TGFB2 protein] results in increased expression of BCL2 mRNA; [Minocycline co-treated with Hydrogen Peroxide co-treated with TGFB2] results in increased expression of BCL2 protein [Minocycline results in increased expression of BCL2 protein] which binds to BAK1 protein; [Minocycline results in increased expression of BCL2 protein] which binds to BAX protein; [Minocycline results in increased expression of BCL2 protein] which binds to BID protein; Sodium Azide inhibits the reaction [Minocycline results in increased expression of BCL2 protein] Minocycline results in increased expression of BCL2 mRNA; Minocycline results in increased expression of BCL2 protein |
CTD |
PMID:15004018 PMID:19807907 PMID:20606027 PMID:20711699 |
|
NCBI chr13:22,689,783...22,853,920
Ensembl chr13:22,684,989...22,853,743 Ensembl chr13:22,684,989...22,853,743
|
|
G |
Bcl2l1 |
Bcl2-like 1 |
multiple interactions |
ISO |
Minocycline inhibits the reaction [Rotenone results in decreased expression of BCL2L1 protein] |
CTD |
PMID:33402167 |
|
NCBI chr 3:141,253,508...141,304,582
Ensembl chr 3:141,253,523...141,303,479
|
|
G |
Bid |
BH3 interacting domain death agonist |
multiple interactions |
ISO EXP |
Minocycline results in decreased activity of and results in decreased cleavage of BID protein [Minocycline results in increased expression of BCL2 protein] which binds to BID protein; Minocycline inhibits the reaction [HTT protein mutant form results in increased cleavage of and results in increased activity of BID protein] |
CTD |
PMID:12930891 PMID:15004018 |
|
NCBI chr 4:154,113,198...154,136,353
Ensembl chr 4:154,113,198...154,134,720
|
|
G |
Casp1 |
caspase 1 |
multiple interactions decreases activity decreases expression |
EXP ISO |
Minocycline inhibits the reaction [HTT protein mutant form results in increased activity of CASP1 protein] Minocycline results in decreased activity of CASP1 protein Minocycline results in decreased expression of CASP1 mRNA; Minocycline results in decreased expression of CASP1 protein |
CTD |
PMID:12930891 PMID:14998631 |
|
NCBI chr 8:2,587,812...2,597,403
Ensembl chr 8:2,587,831...2,597,383
|
|
G |
Casp12 |
caspase 12 |
multiple interactions decreases expression |
EXP |
Minocycline inhibits the reaction [APP protein alternative form results in increased activity of CASP12 protein]; Minocycline results in decreased degradation of [Paraquat results in increased expression of CASP12 protein] Minocycline results in decreased expression of CASP12 mRNA; Minocycline results in decreased expression of CASP12 protein |
CTD |
PMID:14998631 PMID:17406652 PMID:22245251 |
|
NCBI chr 8:2,642,296...2,669,549
Ensembl chr 8:2,642,434...2,674,037
|
|
G |
Casp3 |
caspase 3 |
decreases activity multiple interactions decreases expression |
ISO EXP |
Minocycline results in decreased activity of CASP3 protein Minocycline inhibits the reaction [Kainic Acid results in increased activity of CASP3 protein]; Minocycline inhibits the reaction [Morphine results in increased cleavage of CASP3 protein]; Minocycline inhibits the reaction [Rotenone results in increased cleavage of CASP3 protein]; Minocycline results in decreased activity of and results in decreased cleavage of CASP3 protein Minocycline inhibits the reaction [HTT protein mutant form results in increased activity of CASP3 protein]; Minocycline inhibits the reaction [Morphine results in increased activity of CASP3 protein]; Minocycline inhibits the reaction [Paraquat results in increased cleavage of CASP3 protein]; Minocycline inhibits the reaction [sodium arsenite results in increased cleavage of CASP3 protein]; Minocycline inhibits the reaction [Sodium Azide results in increased activity of CASP3 protein]; Minocycline results in decreased expression of and results in decreased activity of CASP3 protein Minocycline results in decreased expression of CASP3 mRNA Minocycline pretreatment inhibits the reaction [azide increases activity of Casp3 protein in kidney proximal tubular epithelial cells] |
CTD RGD |
PMID:12930891 PMID:14588118 PMID:14998631 PMID:15004018 PMID:15304547 PMID:15564845 PMID:16469440 PMID:17872917 PMID:20711699 PMID:22245251 PMID:33402167 PMID:35939230 PMID:37394652 PMID:15004018 More...
|
RGD:1581919 |
NCBI chr16:45,662,910...45,681,171
Ensembl chr16:45,662,910...45,684,648
|
|
G |
Casp7 |
caspase 7 |
decreases expression multiple interactions |
EXP |
Minocycline results in decreased expression of CASP7 mRNA Minocycline results in decreased expression of and results in decreased activity of CASP7 protein |
CTD |
PMID:14998631 |
|
NCBI chr 1:255,437,438...255,476,737
Ensembl chr 1:255,437,172...255,476,729
|
|
G |
Casp8 |
caspase 8 |
multiple interactions decreases expression |
EXP |
Minocycline inhibits the reaction [HTT protein mutant form results in increased activity of CASP8 protein]; Minocycline inhibits the reaction [sodium arsenite results in increased cleavage of CASP8 protein]; Minocycline results in decreased expression of and results in decreased activity of CASP8 protein Minocycline results in decreased expression of CASP8 mRNA |
CTD |
PMID:12930891 PMID:14998631 PMID:35939230 |
|
NCBI chr 9:60,263,863...60,312,542
Ensembl chr 9:60,264,075...60,312,542
|
|
G |
Casp9 |
caspase 9 |
decreases activity multiple interactions decreases expression |
ISO EXP |
Minocycline results in decreased activity of CASP9 protein Minocycline inhibits the reaction [HTT protein mutant form results in increased activity of CASP9 protein]; Minocycline results in decreased expression of and results in decreased activity of CASP9 protein Minocycline results in decreased expression of CASP9 mRNA |
CTD |
PMID:12930891 PMID:14998631 |
|
NCBI chr 5:154,108,872...154,126,628
Ensembl chr 5:154,109,046...154,126,626
|
|
G |
Ccl2 |
C-C motif chemokine ligand 2 |
decreases expression multiple interactions |
ISO |
Minocycline results in decreased expression of CCL2 protein Minocycline inhibits the reaction [lead acetate results in increased secretion of CCL2 protein] |
CTD |
PMID:20116850 PMID:24530660 |
|
NCBI chr10:67,005,424...67,007,222
Ensembl chr10:67,005,424...67,007,226
|
|
G |
Ccl3 |
C-C motif chemokine ligand 3 |
decreases expression multiple interactions |
ISO |
Minocycline results in decreased expression of CCL3 protein Minocycline inhibits the reaction [[sodium arsenite results in increased abundance of Arsenic] which results in increased secretion of CCL3 protein] |
CTD |
PMID:20116850 PMID:35351628 |
|
NCBI chr10:68,451,388...68,452,938
Ensembl chr10:68,451,388...68,452,938
|
|
G |
Ccl4 |
C-C motif chemokine ligand 4 |
decreases expression |
ISO |
Minocycline results in decreased expression of CCL4 protein |
CTD |
PMID:20116850 |
|
NCBI chr10:68,466,394...68,468,229
Ensembl chr10:68,452,052...68,468,231
|
|
G |
Ccl5 |
C-C motif chemokine ligand 5 |
decreases expression multiple interactions |
ISO |
Minocycline results in decreased expression of CCL5 protein Minocycline inhibits the reaction [[sodium arsenite results in increased abundance of Arsenic] which results in increased secretion of CCL5 protein] |
CTD |
PMID:20116850 PMID:35351628 |
|
NCBI chr10:68,322,826...68,327,380
Ensembl chr10:68,322,829...68,327,377
|
|
G |
Cd68 |
Cd68 molecule |
multiple interactions |
ISO |
Minocycline affects the reaction [[sodium arsenite results in increased abundance of Arsenic] which results in increased expression of CD68 protein]; Minocycline inhibits the reaction [[sodium arsenite results in increased abundance of Arsenic] which results in increased expression of CD68 mRNA] |
CTD |
PMID:35351628 |
|
NCBI chr10:54,381,814...54,383,693
Ensembl chr10:54,381,815...54,383,697
|
|
G |
Cdkn1b |
cyclin-dependent kinase inhibitor 1B |
increases expression |
ISO |
Minocycline results in increased expression of CDKN1B mRNA; Minocycline results in increased expression of CDKN1B protein |
CTD |
PMID:21719015 |
|
NCBI chr 4:167,760,067...167,765,177
Ensembl chr 4:167,760,181...167,764,982
|
|
G |
Cldn5 |
claudin 5 |
increases expression |
EXP |
minocycline increases expression of claudin-5 protein in left corpus callosum of rats with right carotid artery occlusion |
RGD |
PMID:29486300 |
RGD:27095946 |
NCBI chr11:82,212,822...82,214,248
Ensembl chr11:82,211,475...82,214,992
|
|
G |
Cox5a |
cytochrome c oxidase subunit 5A |
multiple interactions |
ISO |
Minocycline inhibits the reaction [[Maneb co-treated with Paraquat] results in decreased expression of COX5A protein] |
CTD |
PMID:23562983 |
|
NCBI chr 8:57,922,374...57,933,781
Ensembl chr 8:57,922,290...57,933,781
|
|
G |
Cycs |
cytochrome c, somatic |
multiple interactions decreases secretion |
ISO EXP |
Minocycline inhibits the reaction [Kainic Acid results in increased localization of CYCS protein] Minocycline results in decreased secretion of CYCS protein Minocycline inhibits the reaction [Cocaine results in increased secretion of CYCS protein]; Minocycline inhibits the reaction [HTT protein mutant form results in increased secretion of CYCS protein] |
CTD |
PMID:12930891 PMID:14998631 PMID:15172883 PMID:16469440 PMID:21424555 |
|
NCBI chr 4:79,651,894...79,653,994
Ensembl chr 4:79,651,378...79,654,054 Ensembl chr18:79,651,378...79,654,054
|
|
G |
Ddit3 |
DNA-damage inducible transcript 3 |
multiple interactions |
EXP |
Minocycline inhibits the reaction [Paraquat results in increased expression of DDIT3 protein] |
CTD |
PMID:22245251 |
|
NCBI chr 7:63,115,645...63,121,203
Ensembl chr 7:63,116,380...63,121,201
|
|
G |
Diablo |
diablo, IAP-binding mitochondrial protein |
decreases secretion multiple interactions |
ISO EXP |
Minocycline results in decreased secretion of DIABLO protein Minocycline inhibits the reaction [HTT protein mutant form results in increased secretion of DIABLO protein]; Minocycline results in decreased secretion of and results in decreased expression of DIABLO protein |
CTD |
PMID:12930891 PMID:14998631 |
|
NCBI chr12:33,055,784...33,070,401
Ensembl chr12:33,055,263...33,070,387
|
|
G |
Dlg1 |
discs large MAGUK scaffold protein 1 |
multiple interactions |
ISO |
Minocycline inhibits the reaction [Rotenone results in decreased expression of DLG1 protein] |
CTD |
PMID:33402167 |
|
NCBI chr11:68,911,883...69,103,230
Ensembl chr11:68,911,883...69,102,689
|
|
G |
Dlg4 |
discs large MAGUK scaffold protein 4 |
multiple interactions |
ISO |
Minocycline affects the reaction [[sodium arsenite results in increased abundance of Arsenic] which results in decreased expression of DLG4 protein] |
CTD |
PMID:35351628 |
|
NCBI chr10:54,740,700...54,769,097
Ensembl chr10:54,739,470...54,767,153
|
|
G |
Dlst |
dihydrolipoamide S-succinyltransferase |
multiple interactions |
ISO |
Minocycline inhibits the reaction [[Maneb co-treated with Paraquat] results in increased expression of DLST protein] |
CTD |
PMID:23562983 |
|
NCBI chr 6:104,758,511...104,783,296
Ensembl chr 6:104,758,631...104,783,296
|
|
G |
Egln1 |
egl-9 family hypoxia-inducible factor 1 |
multiple interactions increases expression |
ISO |
[[Minocycline promotes the reaction [HIF1A protein binds to VHL protein]] co-treated with [Minocycline results in increased expression of EGLN1 protein]] inhibits the reaction [Oxygen deficiency results in increased stability of HIF1A protein]; [[Minocycline promotes the reaction [HIF1A protein binds to VHL protein]] co-treated with [Minocycline results in increased expression of EGLN1 protein]] results in increased degradation of HIF1A protein |
CTD |
PMID:24292262 |
|
NCBI chr19:52,867,900...52,907,308
Ensembl chr19:52,869,486...52,907,777
|
|
G |
Eif2ak2 |
eukaryotic translation initiation factor 2-alpha kinase 2 |
multiple interactions |
EXP |
Minocycline inhibits the reaction [APP protein alternative form results in increased phosphorylation of EIF2AK2 protein] |
CTD |
PMID:17406652 |
|
NCBI chr 6:16,189,000...16,224,972
Ensembl chr 6:16,188,979...16,224,971
|
|
G |
Eif2ak3 |
eukaryotic translation initiation factor 2 alpha kinase 3 |
increases phosphorylation |
EXP |
Minocycline results in increased phosphorylation of EIF2AK3 protein |
CTD |
PMID:22245251 |
|
NCBI chr 4:102,805,495...102,866,914
Ensembl chr 4:102,805,510...102,866,911
|
|
G |
Eif2s1 |
eukaryotic translation initiation factor 2 subunit alpha |
multiple interactions increases phosphorylation |
ISO EXP |
Minocycline inhibits the reaction [APP gene mutant form results in increased phosphorylation of EIF2S1 protein] Minocycline inhibits the reaction [APP protein alternative form results in increased phosphorylation of EIF2S1 protein] Minocycline results in increased phosphorylation of EIF2S1 protein |
CTD |
PMID:17406652 PMID:22245251 |
|
NCBI chr 6:97,672,829...97,697,499
Ensembl chr 6:97,672,766...97,706,225
|
|
G |
Eno1 |
enolase 1 |
multiple interactions |
ISO |
Minocycline inhibits the reaction [1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine results in increased expression of ENO1 protein]; Minocycline inhibits the reaction [[Maneb co-treated with Paraquat] results in increased expression of ENO1 protein] |
CTD |
PMID:23562983 |
|
NCBI chr 5:160,719,951...160,731,337
Ensembl chr 5:160,719,951...160,731,336
|
|
G |
Ern1 |
endoplasmic reticulum to nucleus signaling 1 |
increases phosphorylation |
EXP |
Minocycline results in increased phosphorylation of ERN1 protein |
CTD |
PMID:22245251 |
|
NCBI chr10:91,326,889...91,421,201
Ensembl chr10:91,330,654...91,421,029
|
|
G |
Fmr1 |
fragile X messenger ribonucleoprotein 1 |
multiple interactions |
ISO |
Minocycline inhibits the reaction [FMR1 gene mutant form results in increased expression of and results in increased activity of MMP9 protein] |
CTD |
PMID:18835858 |
|
NCBI chr X:147,240,239...147,278,057
Ensembl chr X:147,240,301...147,278,050
|
|
G |
Gfap |
glial fibrillary acidic protein |
multiple interactions |
ISO |
Minocycline inhibits the reaction [Rotenone results in increased expression of GFAP protein] |
CTD |
PMID:33402167 |
|
NCBI chr10:87,852,891...87,861,631
Ensembl chr10:87,852,890...87,861,589
|
|
G |
Gjc2 |
gap junction protein, gamma 2 |
multiple interactions |
EXP |
Minocycline inhibits the reaction [cypermethrin results in increased expression of GJC2 protein modified form] |
CTD |
PMID:21561882 |
|
NCBI chr10:43,962,642...43,971,358
Ensembl chr10:43,962,642...43,970,467
|
|
G |
Gpx1 |
glutathione peroxidase 1 |
multiple interactions |
ISO |
Minocycline affects the reaction [GPX1 protein affects the expression of AIF1 protein]; Minocycline affects the reaction [GPX1 protein affects the phosphorylation of MAPK1 protein]; Minocycline affects the reaction [GPX1 protein affects the phosphorylation of MAPK3 protein] |
CTD |
PMID:36682417 |
|
NCBI chr 8:109,026,905...109,028,031
Ensembl chr 8:109,026,905...109,028,024
|
|
G |
Gria1 |
glutamate ionotropic receptor AMPA type subunit 1 |
multiple interactions |
EXP |
Minocycline inhibits the reaction [Poly C results in increased expression of GRIA1 mRNA] |
CTD |
PMID:19660546 |
|
NCBI chr10:41,210,713...41,527,283
Ensembl chr10:41,210,713...41,527,283
|
|
G |
Grin2a |
glutamate ionotropic receptor NMDA type subunit 2A |
multiple interactions |
EXP |
Minocycline inhibits the reaction [Poly C results in increased expression of GRIN2A mRNA] |
CTD |
PMID:19660546 |
|
NCBI chr10:5,629,683...6,053,262
Ensembl chr10:5,631,369...6,044,637
|
|
G |
Grin2c |
glutamate ionotropic receptor NMDA type subunit 2C |
multiple interactions |
EXP |
Minocycline inhibits the reaction [Poly C results in increased expression of GRIN2C mRNA] |
CTD |
PMID:19660546 |
|
NCBI chr10:100,488,430...100,507,083
Ensembl chr10:100,488,431...100,506,427
|
|
G |
Gstp1 |
glutathione S-transferase pi 1 |
increases expression |
EXP |
minocycline increases expression of glutathione S-transferase pi protein in left corpus callosum of rats with right carotid artery occlusion |
RGD |
PMID:29486300 |
RGD:27095946 |
NCBI chr 1:201,337,762...201,340,230
Ensembl chr 1:201,321,672...201,340,226
|
|
G |
Hif1a |
hypoxia inducible factor 1 subunit alpha |
multiple interactions increases degradation |
ISO |
[[Minocycline promotes the reaction [HIF1A protein binds to VHL protein]] co-treated with [Minocycline results in increased expression of EGLN1 protein]] inhibits the reaction [Oxygen deficiency results in increased stability of HIF1A protein]; [[Minocycline promotes the reaction [HIF1A protein binds to VHL protein]] co-treated with [Minocycline results in increased expression of EGLN1 protein]] results in increased degradation of HIF1A protein; Minocycline inhibits the reaction [Oxygen deficiency results in increased stability of HIF1A protein]; Minocycline promotes the reaction [HIF1A protein binds to VHL protein] Minocycline results in increased degradation of HIF1A protein |
CTD |
PMID:24292262 |
|
NCBI chr 6:92,624,059...92,669,262
Ensembl chr 6:92,624,390...92,669,261
|
|
G |
Hp |
haptoglobin |
increases expression |
EXP |
minocycline increases expression of zonulin protein in left corpus callosum of rats with right carotid artery occlusion |
RGD |
PMID:29486300 |
RGD:27095946 |
NCBI chr19:37,539,626...37,544,178
Ensembl chr19:37,539,627...37,544,523
|
|
G |
Hspa5 |
heat shock protein family A (Hsp70) member 5 |
multiple interactions |
EXP |
Minocycline inhibits the reaction [Paraquat results in increased expression of HSPA5 protein] |
CTD |
PMID:22245251 |
|
NCBI chr 3:18,055,507...18,059,969
Ensembl chr 3:18,055,405...18,059,891
|
|
G |
Hspd1 |
heat shock protein family D (Hsp60) member 1 |
multiple interactions |
EXP |
Minocycline inhibits the reaction [cypermethrin results in increased expression of HSPD1 protein] |
CTD |
PMID:21561882 |
|
NCBI chr 9:56,579,195...56,590,011
Ensembl chr 9:56,579,201...56,589,662
|
|
G |
Htt |
huntingtin |
multiple interactions |
EXP |
Minocycline inhibits the reaction [HTT protein mutant form results in increased activity of CASP1 protein]; Minocycline inhibits the reaction [HTT protein mutant form results in increased activity of CASP3 protein]; Minocycline inhibits the reaction [HTT protein mutant form results in increased activity of CASP8 protein]; Minocycline inhibits the reaction [HTT protein mutant form results in increased activity of CASP9 protein]; Minocycline inhibits the reaction [HTT protein mutant form results in increased cleavage of and results in increased activity of BID protein]; Minocycline inhibits the reaction [HTT protein mutant form results in increased secretion of and results in increased localization of AIFM1 protein]; Minocycline inhibits the reaction [HTT protein mutant form results in increased secretion of CYCS protein]; Minocycline inhibits the reaction [HTT protein mutant form results in increased secretion of DIABLO protein] |
CTD |
PMID:12930891 |
|
NCBI chr14:75,845,836...75,996,094
Ensembl chr14:75,845,836...75,995,070
|
|
G |
Icam1 |
intercellular adhesion molecule 1 |
decreases expression |
EXP |
Minocycline results in decreased expression of ICAM1 protein |
CTD |
PMID:15172883 |
|
NCBI chr 8:19,553,063...19,565,438
Ensembl chr 8:19,553,645...19,565,438
|
|
G |
Ifng |
interferon gamma |
multiple interactions |
ISO |
Minocycline inhibits the reaction [Trinitrobenzenesulfonic Acid results in increased expression of IFNG mRNA] [Minocycline co-treated with Ionomycin co-treated with Tetradecanoylphorbol Acetate] results in decreased expression of IFNG mRNA |
CTD |
PMID:19285099 PMID:29594315 |
|
NCBI chr 7:53,903,339...53,907,375
Ensembl chr 7:53,903,337...53,907,375
|
|
G |
Il10 |
interleukin 10 |
multiple interactions increases expression |
ISO EXP |
Minocycline promotes the reaction [Lipopolysaccharides results in increased expression of IL10 mRNA] Minocycline results in increased expression of IL10 mRNA |
CTD |
PMID:14588118 PMID:22024136 |
|
NCBI chr13:42,472,625...42,477,308
Ensembl chr13:42,472,839...42,477,313
|
|
G |
Il1b |
interleukin 1 beta |
multiple interactions affects secretion |
ISO EXP |
Minocycline inhibits the reaction [Cisplatin results in increased expression of IL1B mRNA]; Minocycline inhibits the reaction [Dextran Sulfate results in increased expression of IL1B mRNA]; Minocycline inhibits the reaction [Lipopolysaccharides results in increased expression of IL1B mRNA]; Minocycline inhibits the reaction [Morphine results in increased expression of IL1B protein]; Minocycline inhibits the reaction [Paraquat results in increased expression of IL1B protein]; Minocycline inhibits the reaction [Rotenone results in increased expression of IL1B mRNA]; Minocycline inhibits the reaction [T-2 Toxin results in increased expression of IL1B mRNA] Minocycline affects the secretion of IL1B protein Minocycline inhibits the reaction [Kainic Acid results in increased secretion of IL1B protein]; Minocycline inhibits the reaction [lead acetate results in increased secretion of IL1B protein]; Minocycline inhibits the reaction [manganese chloride results in increased expression of IL1B protein]; Minocycline inhibits the reaction [Paclitaxel results in increased expression of IL1B protein]; Minocycline inhibits the reaction [Toluene results in increased expression of IL1B mRNA] |
CTD |
PMID:11306611 PMID:16386803 PMID:18836210 PMID:19285099 PMID:22024136 PMID:22952811 PMID:32234516 PMID:33402167 PMID:36775139 PMID:37394652 PMID:37769865 PMID:38189626 PMID:38459698 More...
|
|
NCBI chr 3:116,577,005...116,583,386
Ensembl chr 3:116,577,010...116,583,415
|
|
G |
Il2 |
interleukin 2 |
multiple interactions |
ISO |
[Minocycline co-treated with Ionomycin co-treated with Tetradecanoylphorbol Acetate] results in decreased expression of IL2 mRNA |
CTD |
PMID:29594315 |
|
NCBI chr 2:120,004,862...120,009,566
Ensembl chr 2:120,004,862...120,009,566
|
|
G |
Il6 |
interleukin 6 |
multiple interactions |
ISO |
Minocycline inhibits the reaction [[sodium arsenite results in increased abundance of Arsenic] which results in increased secretion of IL6 protein]; Minocycline inhibits the reaction [Dextran Sulfate results in increased expression of IL6 mRNA]; Minocycline inhibits the reaction [Dietary Fats results in increased expression of IL6 protein]; Minocycline inhibits the reaction [lead acetate results in increased secretion of IL6 protein]; Minocycline inhibits the reaction [Methamphetamine results in increased secretion of IL6 protein]; Minocycline inhibits the reaction [Morphine results in increased expression of IL6 protein]; Minocycline inhibits the reaction [Paraquat results in increased expression of IL6 protein]; Minocycline inhibits the reaction [T-2 Toxin results in increased expression of IL6 mRNA] |
CTD |
PMID:19285099 PMID:21719015 PMID:24530660 PMID:32916201 PMID:35351628 PMID:36775139 PMID:37394652 PMID:38189626 More...
|
|
NCBI chr 4:5,214,602...5,219,178
Ensembl chr 4:5,213,394...5,219,178
|
|
G |
Il6r |
interleukin 6 receptor |
decreases expression |
ISO |
Minocycline results in decreased expression of IL6R protein modified form |
CTD |
PMID:20116850 |
|
NCBI chr 2:175,289,157...175,347,719
Ensembl chr 2:175,298,686...175,347,536
|
|
G |
Ina |
internexin neuronal intermediate filament protein, alpha |
multiple interactions |
EXP |
Minocycline inhibits the reaction [cypermethrin results in increased expression of INA protein] |
CTD |
PMID:21561882 |
|
NCBI chr 1:245,896,775...245,908,330
Ensembl chr 1:245,896,775...245,908,330
|
|
G |
Itgam |
integrin subunit alpha M |
multiple interactions |
ISO |
Minocycline inhibits the reaction [Paraquat results in increased expression of ITGAM protein]; Minocycline inhibits the reaction [Paraquat results in increased phosphorylation of ITGAM protein]; Minocycline inhibits the reaction [T-2 Toxin results in increased expression of ITGAM protein] |
CTD |
PMID:36775139 PMID:38189626 |
|
NCBI chr 1:182,659,047...182,709,501
Ensembl chr 1:182,659,000...182,709,503
|
|
G |
Jun |
Jun proto-oncogene, AP-1 transcription factor subunit |
multiple interactions |
ISO |
Minocycline results in decreased phosphorylation of and results in decreased activity of and results in decreased expression of JUN protein |
CTD |
PMID:17872917 |
|
NCBI chr 5:109,894,175...109,897,268
Ensembl chr 5:109,893,145...109,897,656
|
|
G |
Mapk1 |
mitogen activated protein kinase 1 |
increases phosphorylation multiple interactions |
ISO |
Minocycline results in increased phosphorylation of MAPK1 protein Minocycline affects the reaction [GPX1 protein affects the phosphorylation of MAPK1 protein] |
CTD |
PMID:36682417 |
|
NCBI chr11:83,957,813...84,023,629
Ensembl chr11:83,957,813...84,023,616
|
|
G |
Mapk3 |
mitogen activated protein kinase 3 |
multiple interactions increases phosphorylation |
ISO |
Minocycline affects the reaction [GPX1 protein affects the phosphorylation of MAPK3 protein] Minocycline results in increased phosphorylation of MAPK3 protein |
CTD |
PMID:36682417 |
|
NCBI chr 1:181,366,646...181,372,863
Ensembl chr 1:181,366,637...181,372,863
|
|
G |
Mapk8 |
mitogen-activated protein kinase 8 |
decreases phosphorylation |
ISO |
Minocycline results in decreased phosphorylation of MAPK8 protein |
CTD |
PMID:17872917 |
|
NCBI chr16:8,638,897...8,721,960
Ensembl chr16:8,638,924...8,721,981
|
|
G |
Mapkapk5 |
MAPK activated protein kinase 5 |
multiple interactions |
EXP |
Minocycline inhibits the reaction [cypermethrin results in increased expression of MAPKAPK5 protein] |
CTD |
PMID:21561882 |
|
NCBI chr12:34,993,520...35,013,059
Ensembl chr12:34,994,092...35,013,052
|
|
G |
Mlkl |
mixed lineage kinase domain like pseudokinase |
multiple interactions |
EXP |
Minocycline inhibits the reaction [Paclitaxel results in increased expression of MLKL protein] |
CTD |
PMID:38459698 |
|
NCBI chr19:39,277,526...39,304,555
Ensembl chr19:39,276,785...39,304,502
|
|
G |
Mmp13 |
matrix metallopeptidase 13 |
increases expression multiple interactions |
ISO |
Minocycline results in increased expression of MMP13 mRNA Minocycline inhibits the reaction [Dextran Sulfate results in increased expression of MMP13 mRNA] |
CTD |
PMID:19285099 PMID:20338993 |
|
NCBI chr 8:4,497,960...4,508,239
Ensembl chr 8:4,497,960...4,508,239
|
|
G |
Mmp2 |
matrix metallopeptidase 2 |
decreases expression decreases activity multiple interactions |
ISO EXP |
Minocycline results in decreased expression of MMP2 protein Minocycline results in decreased activity of MMP2 protein Minocycline inhibits the reaction [Dextran Sulfate results in increased expression of MMP2 mRNA]; Minocycline inhibits the reaction [Dextran Sulfate results in increased expression of MMP2 protein] Minocycline inhibits the reaction [Oxygen deficiency results in increased expression of MMP2 mRNA] |
CTD |
PMID:11835378 PMID:14508231 PMID:16846501 PMID:19285099 PMID:24292262 |
|
NCBI chr19:14,154,657...14,182,870
Ensembl chr19:14,154,657...14,182,870
|
|
G |
Mmp3 |
matrix metallopeptidase 3 |
multiple interactions |
ISO |
Minocycline inhibits the reaction [Dextran Sulfate results in increased expression of MMP3 mRNA] |
CTD |
PMID:19285099 |
|
NCBI chr 8:4,640,397...4,653,963
Ensembl chr 8:4,640,416...4,653,961
|
|
G |
Mmp9 |
matrix metallopeptidase 9 |
multiple interactions decreases expression decreases activity |
ISO EXP |
Minocycline inhibits the reaction [Dextran Sulfate results in increased expression of MMP9 mRNA]; Minocycline inhibits the reaction [Dextran Sulfate results in increased expression of MMP9 protein]; Minocycline inhibits the reaction [FMR1 gene mutant form results in increased expression of and results in increased activity of MMP9 protein] Minocycline results in decreased expression of MMP9 protein Minocycline results in decreased activity of MMP9 protein |
CTD |
PMID:16846501 PMID:18835858 PMID:19285099 |
|
NCBI chr 3:153,684,158...153,692,118
Ensembl chr 3:153,683,858...153,692,120
|
|
G |
Mr1 |
major histocompatibility complex, class I-related |
affects expression |
ISO |
Minocycline affects the expression of MR1 mRNA |
CTD |
PMID:25811541 |
|
NCBI chr13:67,298,362...67,317,985
Ensembl chr13:67,299,585...67,317,970
|
|
G |
Ncf1 |
neutrophil cytosolic factor 1 |
multiple interactions |
ISO |
Minocycline inhibits the reaction [Paraquat affects the localization of NCF1 protein] |
CTD |
PMID:38189626 |
|
NCBI chr12:22,485,382...22,494,647
Ensembl chr12:22,485,451...22,494,646
|
|
G |
Nlrp3 |
NLR family, pyrin domain containing 3 |
multiple interactions |
ISO |
Minocycline inhibits the reaction [Morphine results in increased expression of NLRP3 protein] |
CTD |
PMID:37394652 |
|
NCBI chr10:44,326,770...44,353,814
Ensembl chr10:44,328,566...44,352,811
|
|
G |
Nos2 |
nitric oxide synthase 2 |
multiple interactions |
ISO EXP |
Minocycline inhibits the reaction [Dextran Sulfate results in increased expression of NOS2 mRNA]; Minocycline inhibits the reaction [Dextran Sulfate results in increased expression of NOS2 protein]; Minocycline inhibits the reaction [Morphine results in increased expression of NOS2 protein]; Minocycline inhibits the reaction [Paraquat results in increased expression of NOS2 protein]; Minocycline inhibits the reaction [Rotenone results in increased expression of NOS2 mRNA]; Minocycline inhibits the reaction [Trinitrobenzenesulfonic Acid results in increased expression of NOS2 mRNA] Minocycline inhibits the reaction [lead acetate results in increased expression of NOS2 protein]; Minocycline inhibits the reaction [Lipopolysaccharides results in increased expression of NOS2 mRNA]; Minocycline inhibits the reaction [Lipopolysaccharides results in increased expression of NOS2 protein]; Minocycline inhibits the reaction [manganese chloride results in increased expression of NOS2 protein] |
CTD |
PMID:15485488 PMID:18836210 PMID:19285099 PMID:22952811 PMID:33402167 PMID:37394652 PMID:38189626 More...
|
|
NCBI chr10:63,815,308...63,851,208
Ensembl chr10:63,815,308...63,851,210
|
|
G |
Ocln |
occludin |
increases expression |
EXP |
minocycline increases expression of occludin protein in left corpus callosum of rats with right carotid artery occlusion |
RGD |
PMID:29486300 |
RGD:27095946 |
NCBI chr 2:31,657,217...31,707,466
Ensembl chr 2:31,657,220...31,764,150
|
|
G |
Pafah1b2 |
platelet-activating factor acetylhydrolase 1b, catalytic subunit 2 |
multiple interactions |
EXP |
Minocycline inhibits the reaction [cypermethrin results in decreased expression of PAFAH1B2 protein] |
CTD |
PMID:21561882 |
|
NCBI chr 8:46,260,069...46,312,073
Ensembl chr 8:46,261,064...46,279,833
|
|
G |
Pdk1 |
pyruvate dehydrogenase kinase 1 |
multiple interactions |
ISO |
Minocycline inhibits the reaction [Paraquat results in increased expression of PDK1 protein] |
CTD |
PMID:38189626 |
|
NCBI chr 3:56,705,824...56,733,040
Ensembl chr 3:56,705,871...56,733,038
|
|
G |
Pik3cb |
phosphatidylinositol-4,5-bisphosphate 3-kinase, catalytic subunit beta |
multiple interactions |
ISO |
Minocycline inhibits the reaction [Paraquat results in increased expression of PIK3CB protein] |
CTD |
PMID:38189626 |
|
NCBI chr 8:99,594,600...99,699,772
Ensembl chr 8:99,594,644...99,699,663
|
|
G |
Prdx2 |
peroxiredoxin 2 |
multiple interactions |
ISO |
Minocycline inhibits the reaction [1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine results in decreased expression of PRDX2 protein] |
CTD |
PMID:23562983 |
|
NCBI chr19:23,180,927...23,186,217
Ensembl chr19:23,180,930...23,186,194
|
|
G |
Prdx3 |
peroxiredoxin 3 |
multiple interactions |
ISO |
Minocycline inhibits the reaction [1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine results in decreased expression of PRDX3 protein]; Minocycline inhibits the reaction [[Maneb co-treated with Paraquat] results in decreased expression of PRDX3 protein] |
CTD |
PMID:23562983 |
|
NCBI chr 1:260,001,642...260,014,064
Ensembl chr 1:260,001,637...260,014,111
|
|
G |
Prkn |
parkin RBR E3 ubiquitin protein ligase |
multiple interactions |
ISO |
Minocycline inhibits the reaction [PRKN gene mutant form results in increased susceptibility to Rotenone] |
CTD |
PMID:16573651 |
|
NCBI chr 1:48,688,651...49,882,520
Ensembl chr 1:48,690,556...49,882,555
|
|
G |
Prtn3 |
proteinase 3 |
increases expression |
ISO |
Minocycline results in increased expression of PRTN3 protein |
CTD |
PMID:12900849 |
|
NCBI chr 7:9,822,123...9,831,300
Ensembl chr 7:9,822,122...9,831,944
|
|
G |
Ptgs1 |
prostaglandin-endoperoxide synthase 1 |
multiple interactions |
EXP |
Minocycline inhibits the reaction [Morphine results in increased expression of PTGS1 mRNA] |
CTD |
PMID:18706994 |
|
NCBI chr 3:19,584,015...19,605,589
Ensembl chr 3:19,584,015...19,605,586
|
|
G |
Ptgs2 |
prostaglandin-endoperoxide synthase 2 |
multiple interactions |
ISO |
Minocycline inhibits the reaction [Cisplatin results in increased expression of PTGS2 mRNA]; Minocycline inhibits the reaction [Morphine results in increased expression of PTGS2 protein]; Minocycline inhibits the reaction [T-2 Toxin results in increased expression of PTGS2 mRNA]; Minocycline inhibits the reaction [T-2 Toxin results in increased expression of PTGS2 protein] |
CTD |
PMID:36775139 PMID:37394652 PMID:37769865 |
|
NCBI chr13:62,163,936...62,172,193
Ensembl chr13:62,163,932...62,172,188
|
|
G |
Pycard |
PYD and CARD domain containing |
multiple interactions |
ISO |
Minocycline inhibits the reaction [Morphine results in increased expression of PYCARD protein] |
CTD |
PMID:37394652 |
|
NCBI chr 1:182,601,657...182,603,013
Ensembl chr 1:182,601,174...182,602,955
|
|
G |
Rbfox3 |
RNA binding fox-1 homolog 3 |
multiple interactions |
ISO |
Minocycline inhibits the reaction [Paraquat results in decreased expression of RBFOX3 protein]; Minocycline inhibits the reaction [Rotenone results in decreased expression of RBFOX3 protein] |
CTD |
PMID:33402167 PMID:38189626 |
|
NCBI chr10:103,720,355...104,157,277
Ensembl chr10:103,720,636...104,156,935
|
|
G |
Rela |
RELA proto-oncogene, NF-kB subunit |
affects expression |
ISO |
Minocycline affects the expression of RELA protein |
CTD |
PMID:17898303 |
|
NCBI chr 1:202,925,001...202,935,484
Ensembl chr 1:202,924,945...202,935,484
|
|
G |
Ripk3 |
receptor-interacting serine-threonine kinase 3 |
multiple interactions |
EXP |
Minocycline inhibits the reaction [Paclitaxel results in increased expression of RIPK3 protein] |
CTD |
PMID:38459698 |
|
NCBI chr15:29,283,153...29,292,107
Ensembl chr15:29,283,145...29,292,121
|
|
G |
RT1-CE16 |
RT1 class I, locus CE16 |
affects expression |
ISO |
Minocycline affects the expression of HLA-A mRNA |
CTD |
PMID:25811541 |
|
NCBI chr20:3,257,109...3,260,747
Ensembl chr20:3,257,123...3,279,563
|
|
G |
RT1-CE5 |
RT1 class I, locus CE5 |
affects expression |
ISO |
Minocycline affects the expression of HLA-F mRNA |
CTD |
PMID:25811541 |
|
NCBI chr20:3,403,418...3,479,476
|
|
G |
Slc22a6 |
solute carrier family 22 member 6 |
multiple interactions |
ISO |
Minocycline inhibits the reaction [SLC22A6 protein results in increased uptake of Anions] |
CTD |
PMID:11855680 |
|
NCBI chr 1:205,522,579...205,531,179
Ensembl chr 1:205,522,729...205,531,173
|
|
G |
Slc22a7 |
solute carrier family 22 member 7 |
multiple interactions |
ISO |
Minocycline inhibits the reaction [SLC22A7 protein results in increased uptake of Anions] |
CTD |
PMID:11855680 |
|
NCBI chr 9:14,547,073...14,554,354
Ensembl chr 9:14,547,849...14,553,921
|
|
G |
Slc2a1 |
solute carrier family 2 member 1 |
multiple interactions |
ISO |
Minocycline inhibits the reaction [Oxygen deficiency results in increased expression of SLC2A1 mRNA] |
CTD |
PMID:24292262 |
|
NCBI chr 5:132,717,196...132,745,416
Ensembl chr 5:132,717,196...132,745,416
|
|
G |
Slc6a3 |
solute carrier family 6 member 3 |
multiple interactions |
ISO |
Minocycline inhibits the reaction [Methamphetamine results in decreased expression of SLC6A3 protein]; Minocycline inhibits the reaction [Paraquat results in decreased expression of SLC6A3 protein] |
CTD |
PMID:16839653 PMID:38189626 |
|
NCBI chr 1:29,709,443...29,750,413
Ensembl chr 1:29,709,443...29,750,413
|
|
G |
Snap25 |
synaptosome associated protein 25 |
multiple interactions |
EXP |
Minocycline inhibits the reaction [cypermethrin results in decreased expression of SNAP25 protein] |
CTD |
PMID:21561882 |
|
NCBI chr 3:124,041,898...124,123,761
Ensembl chr 3:124,041,898...124,123,760
|
|
G |
Sod2 |
superoxide dismutase 2 |
multiple interactions |
ISO |
Minocycline inhibits the reaction [[Maneb co-treated with Paraquat] results in decreased expression of SOD2 protein] |
CTD |
PMID:23562983 |
|
NCBI chr 1:47,638,318...47,645,163
Ensembl chr 1:47,636,528...47,645,189
|
|
G |
Stmn1 |
stathmin 1 |
multiple interactions |
EXP ISO |
Minocycline inhibits the reaction [cypermethrin results in decreased expression of STMN1 protein] Minocycline inhibits the reaction [[Maneb co-treated with Paraquat] results in decreased expression of STMN1 protein] |
CTD |
PMID:21561882 PMID:23562983 |
|
NCBI chr 5:146,680,757...146,687,154
Ensembl chr 5:146,681,436...146,687,154
|
|
G |
Tgfb1 |
transforming growth factor, beta 1 |
increases expression multiple interactions |
EXP |
Minocycline results in increased expression of TGFB1 mRNA Minocycline inhibits the reaction [Toluene results in decreased expression of TGFB1 mRNA] |
CTD |
PMID:32234516 |
|
NCBI chr 1:81,196,532...81,212,848
Ensembl chr 1:81,196,532...81,212,847
|
|
G |
Tgfb2 |
transforming growth factor, beta 2 |
multiple interactions |
ISO |
[Minocycline co-treated with Hydrogen Peroxide co-treated with TGFB2 protein] results in increased expression of BCL2 mRNA; [Minocycline co-treated with Hydrogen Peroxide co-treated with TGFB2] results in increased expression of BCL2 protein; [Minocycline co-treated with Hydrogen Peroxide co-treated with TGFB2] results in increased expression of XIAP mRNA; [Minocycline co-treated with Hydrogen Peroxide co-treated with TGFB2] results in increased expression of XIAP protein |
CTD |
PMID:20606027 |
|
NCBI chr13:98,160,075...98,261,771
Ensembl chr13:98,160,087...98,261,405
|
|
G |
Th |
tyrosine hydroxylase |
multiple interactions |
ISO |
Minocycline inhibits the reaction [Paraquat results in decreased expression of TH protein] |
CTD |
PMID:38189626 |
|
NCBI chr 1:198,071,500...198,078,832
Ensembl chr 1:198,071,503...198,109,767
|
|
G |
Tnf |
tumor necrosis factor |
multiple interactions decreases expression |
EXP ISO |
Minocycline inhibits the reaction [lead acetate results in increased secretion of TNF protein]; Minocycline inhibits the reaction [Lipopolysaccharides results in increased expression of TNF mRNA]; Minocycline inhibits the reaction [manganese chloride results in increased expression of TNF protein]; Minocycline inhibits the reaction [Paclitaxel results in increased expression of TNF protein] Minocycline results in decreased expression of TNF mRNA Minocycline inhibits the reaction [[sodium arsenite results in increased abundance of Arsenic] which results in increased secretion of TNF protein]; Minocycline inhibits the reaction [Cisplatin results in increased expression of TNF mRNA]; Minocycline inhibits the reaction [Dextran Sulfate results in increased expression of TNF mRNA]; Minocycline inhibits the reaction [Dietary Fats results in increased expression of TNF protein]; Minocycline inhibits the reaction [lead acetate results in increased secretion of TNF protein]; Minocycline inhibits the reaction [Methamphetamine results in increased secretion of TNF protein]; Minocycline inhibits the reaction [Morphine results in increased expression of TNF protein]; Minocycline inhibits the reaction [Paraquat results in increased expression of TNF protein]; Minocycline inhibits the reaction [Rotenone results in increased expression of TNF mRNA]; Minocycline inhibits the reaction [T-2 Toxin results in increased expression of TNF mRNA]; Minocycline inhibits the reaction [Trinitrobenzenesulfonic Acid results in increased expression of TNF mRNA] |
CTD |
PMID:14588118 PMID:15485488 PMID:18836210 PMID:19285099 PMID:21719015 PMID:22952811 PMID:24530660 PMID:32916201 PMID:33402167 PMID:35351628 PMID:36775139 PMID:37394652 PMID:37769865 PMID:38189626 PMID:38459698 More...
|
|
NCBI chr20:3,622,011...3,624,629
Ensembl chr20:3,622,011...3,624,629
|
|
G |
Tp53 |
tumor protein p53 |
decreases expression |
EXP |
Minocycline results in decreased expression of TP53 protein |
CTD |
PMID:15172883 |
|
NCBI chr10:54,300,070...54,311,525
Ensembl chr10:54,300,048...54,311,524
|
|
G |
Tpo |
thyroid peroxidase |
decreases activity |
EXP |
Minocycline results in decreased activity of TPO protein |
CTD |
PMID:26884060 |
|
NCBI chr 6:46,698,402...46,768,199
Ensembl chr 6:46,698,414...46,768,199
|
|
G |
Trem2 |
triggering receptor expressed on myeloid cells 2 |
multiple interactions |
ISO |
Minocycline inhibits the reaction [[sodium arsenite results in increased abundance of Arsenic] which results in increased expression of TREM2 mRNA] |
CTD |
PMID:35351628 |
|
NCBI chr 9:12,647,605...12,654,190
Ensembl chr 9:12,647,259...12,654,170
|
|
G |
Tuba1a |
tubulin, alpha 1A |
multiple interactions |
ISO |
Minocycline inhibits the reaction [[Maneb co-treated with Paraquat] results in increased expression of TUBA1A protein] |
CTD |
PMID:23562983 |
|
NCBI chr 7:130,113,214...130,116,880
Ensembl chr 7:130,081,032...130,196,186
|
|
G |
Vegfa |
vascular endothelial growth factor A |
decreases expression |
ISO |
Minocycline results in decreased expression of VEGFA protein |
CTD |
PMID:20116850 |
|
NCBI chr 9:14,955,300...14,970,641
Ensembl chr 9:14,955,300...14,970,641
|
|
G |
Vegfc |
vascular endothelial growth factor C |
multiple interactions |
ISO |
Minocycline inhibits the reaction [Oxygen deficiency results in increased expression of VEGFC mRNA] |
CTD |
PMID:24292262 |
|
NCBI chr16:37,712,251...37,827,845
Ensembl chr16:37,712,262...37,827,848
|
|
G |
Vegfd |
vascular endothelial growth factor D |
multiple interactions |
ISO |
Minocycline inhibits the reaction [Oxygen deficiency results in increased expression of VEGFD mRNA] |
CTD |
PMID:24292262 |
|
NCBI chr X:30,073,122...30,108,413
Ensembl chr X:30,074,163...30,108,295
|
|
G |
Vhl |
von Hippel-Lindau tumor suppressor |
multiple interactions |
ISO |
[[Minocycline promotes the reaction [HIF1A protein binds to VHL protein]] co-treated with [Minocycline results in increased expression of EGLN1 protein]] inhibits the reaction [Oxygen deficiency results in increased stability of HIF1A protein]; [[Minocycline promotes the reaction [HIF1A protein binds to VHL protein]] co-treated with [Minocycline results in increased expression of EGLN1 protein]] results in increased degradation of HIF1A protein; Minocycline promotes the reaction [HIF1A protein binds to VHL protein] |
CTD |
PMID:24292262 |
|
NCBI chr 4:146,772,483...146,779,376
Ensembl chr 4:146,772,468...146,779,377
|
|
G |
Xbp1 |
X-box binding protein 1 |
multiple interactions |
EXP |
Minocycline inhibits the reaction [Paraquat results in increased expression of XBP1 protein] |
CTD |
PMID:22245251 |
|
NCBI chr14:80,390,629...80,395,713
Ensembl chr14:80,390,643...80,395,693
|
|
G |
Xiap |
X-linked inhibitor of apoptosis |
increases expression multiple interactions |
EXP ISO |
Minocycline results in increased expression of XIAP protein [Minocycline co-treated with Hydrogen Peroxide co-treated with TGFB2] results in increased expression of XIAP mRNA; [Minocycline co-treated with Hydrogen Peroxide co-treated with TGFB2] results in increased expression of XIAP protein |
CTD |
PMID:14998631 PMID:20606027 |
|
NCBI chr X:120,890,537...120,938,413
Ensembl chr X:120,897,907...120,934,700
|
|